Variant report
Variant | esv995052 |
---|---|
Chromosome Location | chr5:106232927-106241625 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540610222 | chr5:106232930-106232931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560834875 | chr5:106232935-106232936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143854063 | chr5:106232939-106232940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545403719 | chr5:106232962-106232963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529236679 | chr5:106232992-106232993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs58797261 | chr5:106233001-106233002 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs547867160 | chr5:106233028-106233029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370259184 | chr5:106233032-106233033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527480701 | chr5:106233033-106233034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564397145 | chr5:106233063-106233064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146330399 | chr5:106233067-106233068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370750482 | chr5:106233192-106233193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201018822 | chr5:106233194-106233195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs71575428 | chr5:106233195-106233196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557328082 | chr5:106233196-106233197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs202211506 | chr5:106233208-106233209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs70996938 | chr5:106233209-106233210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200390017 | chr5:106233210-106233211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201853574 | chr5:106233212-106233213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201407341 | chr5:106233213-106233214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201295856 | chr5:106233214-106233215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs71586573 | chr5:106233232-106233233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs66946770 | chr5:106233233-106233234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs367765266 | chr5:106233238-106233239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371015549 | chr5:106233239-106233240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183041097 | chr5:106233249-106233250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs60098391 | chr5:106233250-106233251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374600412 | chr5:106233265-106233266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142965010 | chr5:106233267-106233268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564807610 | chr5:106233269-106233270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs70996939 | chr5:106233277-106233278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188552467 | chr5:106233286-106233287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35399767 | chr5:106233305-106233306 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs538375157 | chr5:106233310-106233311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1266133 | chr5:106233343-106233344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs35781242 | chr5:106233345-106233346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114475608 | chr5:106233348-106233349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534407394 | chr5:106233412-106233413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528879977 | chr5:106233429-106233430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554031949 | chr5:106233432-106233433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577140655 | chr5:106233442-106233443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78484543 | chr5:106233450-106233451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs193084662 | chr5:106233474-106233475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142611498 | chr5:106233504-106233505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575623810 | chr5:106233535-106233536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541609631 | chr5:106233537-106233538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2463036 | chr5:106233542-106233543 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs2463037 | chr5:106233551-106233552 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs2454889 | chr5:106233578-106233579 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs564095836 | chr5:106233608-106233609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16773561 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:106231400-106233400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
2 | chr5:106233400-106234400 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr5:106240000-106240800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr5:106240000-106241000 | Active TSS | HUES64 Cell Line | embryonic stem cell |
5 | chr5:106240200-106241000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
6 | chr5:106240200-106241200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
7 | chr5:106240200-106241400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr5:106240400-106240800 | Active TSS | H9 Cell Line | embryonic stem cell |
9 | chr5:106240600-106240800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr5:106240600-106241200 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
11 | chr5:106241000-106241800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr5:106241000-106242200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr5:106241000-106242400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr5:106241000-106242600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr5:106241200-106241800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr5:106241200-106242400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |